Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Open-label Clinical Study of rhPTH(1-84) Treatment in Japanese Subjects With Chronic Hypoparathyroidism

NCT03878953 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT03878953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03878953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Open-label Clinical Study of rhPTH(1-84) Treatment in Japanese Subjects With Chronic Hypoparathyroidism
Lead sponsor
Shire
Phase
Phase 3
Overall status
Withdrawn
Start date
August 31, 2022
Completion date
May 31, 2023
Enrollment
0 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hypoparathyroidism